IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia)
Huo, Yong1; Lee, Stephen W. -L.2; Sawhney, Jitendra P. S.3; Kim, Hyo-Soo4; Krittayaphong, Rungroj5; Nhan, Vo T.6; Alonso-Garcia, Angeles7; Han, Ya Ling8; Ge, Junbo9; Chin, Chee Tang10,11; Ong, Tiong K.12; Jan, Stephen13; Itoh, Yohji14; Vega, Ana Maria15; Pocock, Stuart16
刊名CLINICAL CARDIOLOGY
2015-09-01
DOI10.1002/clc.22431
38期:9页:511-519
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems
研究领域[WOS]Cardiovascular System & Cardiology
关键词[WOS]ST-SEGMENT ELEVATION ; ACUTE MYOCARDIAL-INFARCTION ; ASSOCIATION TASK-FORCE ; BLEEDING COMPLICATIONS ; ATRIAL-FIBRILLATION ; PRACTICE GUIDELINES ; SYNDROME REGISTRY ; CLOPIDOGREL ; THERAPY ; INTERVENTION
英文摘要

BackgroundIn-hospital and postdischarge mortality for acute coronary syndromes (ACS) vary across Asia and remain generally poorer than globally. The relationship between real-life antithrombotic management patterns (AMPs) and ACS-related outcomes in Asia is unclear.

MethodsEPICOR Asia (Long-tErm follow-uP of antithrombotic management patterns In acute CORonary syndrome patients in Asia) (NCT01361386) is a prospective, multinational, observational study of patients discharged after hospitalization for an ACS, with 2-year follow-up. The aim is to describe short- and long-term (up to 2 years post-index event) AMPs in patients hospitalized for ACS and to record clinical outcomes, healthcare resource use, and self-reported health status. Pre- and in-hospital management, AMPs, and associated outcomes, with particular focus on ischemic and bleeding events, will be recorded during the 2-year follow up.

ResultsBetween June 2011 and May 2012, 13 005 patients were enrolled. From these, 12 922 patients surviving an ACS (6616 with STEMI, 2570 with NSTEMI, and 3736 with UA) were eligible for inclusion from 219 hospitals across 8 countries and regions in Asia: China (n = 8214), Hong Kong (n = 177), India (n = 2468), Malaysia (n = 100), Singapore (n = 93), South Korea (n = 705), Thailand (n = 957), and Vietnam (n = 208).

ConclusionsEPICOR Asia will provide information regarding clinical management and AMPs for ACS patients in Asia. Impact of AMPs on clinical outcomes, healthcare resource use, and self-reported health status both during hospitalization and up to 2 years after discharge will also be described.

语种英语
WOS记录号WOS:000362093000001
资助机构AstraZeneca ; Servier ; Sanofi ; Salubris Pharmaceutical Co. Ltd. ; Yi Sheng Pharmaceutical Co. Ltd. ; Shandong Huaan Pharmaceutical Co. Ltd. ; MicroPort Corporation ; Abbott Laboratories ; Eli Lilly ; Roche ; Boston Scientific
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65596
专题北京大学第一临床医学院_心血管内科
作者单位1.Shenyang Northern Hosp, Dept Cardiol, Shenyang, Peoples R China
2.Zhongshan Hosp, Dept Cardiol, Shanghai, Peoples R China
3.Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
4.Duke NUS Grad Med Sch, Singapore, Singapore
5.Sarawak Gen Hosp, Dept Cardiol, Kuching, Malaysia
6.AstraZeneca, Div Clin Sci, Osaka, Japan
7.AstraZeneca, Global Med Affairs, Observat Res Ctr, Madrid, Spain
8.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China
9.Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
10.Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea
11.Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok 10700, Thailand
12.St Georges Univ London, Cardiovasc Sci Res Ctr, London, England
13.Univ Sydney, Hlth Econ Program, George Inst Global Hlth, Sydney, NSW 2006, Australia
14.London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England
15.Sir Ganga Ram Hosp, Dept Cardiol, New Delhi, India
16.Cho Ray Hosp, Dept Med, Ho Chi Minh City, Vietnam
推荐引用方式
GB/T 7714
Huo, Yong,Lee, Stephen W. -L.,Sawhney, Jitendra P. S.,et al. Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia)[J]. CLINICAL CARDIOLOGY,2015,38(9):511-519.
APA Huo, Yong.,Lee, Stephen W. -L..,Sawhney, Jitendra P. S..,Kim, Hyo-Soo.,Krittayaphong, Rungroj.,...&Pocock, Stuart.(2015).Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia).CLINICAL CARDIOLOGY,38(9),511-519.
MLA Huo, Yong,et al."Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-tErm follow-uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia)".CLINICAL CARDIOLOGY 38.9(2015):511-519.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Huo, Yong]的文章
[Lee, Stephen W. -L.]的文章
[Sawhney, Jitendra P. S.]的文章
百度学术
百度学术中相似的文章
[Huo, Yong]的文章
[Lee, Stephen W. -L.]的文章
[Sawhney, Jitendra P. S.]的文章
必应学术
必应学术中相似的文章
[Huo, Yong]的文章
[Lee, Stephen W. -L.]的文章
[Sawhney, Jitendra P. S.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。